Target Name: WFDC21P
NCBI ID: G645638
Other Name(s): LNCDC | linc-DC | WAP four-disulfide core domain 21, pseudogene | lnc-DC

WFDC21P: A Protein Involved in Disease Development

WFDC21P (Wilmsen Family DNA-Coded 21-Person Disease Controlled Protein) is a protein that is expressed in nearly all human tissues and is involved in the development and progression of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. Its function and significance have been studied extensively in the scientific literature, and there is growing interest in using it as a drug target or biomarker.

The Wilmsen family of proteins is a family of transcription factors that are involved in the regulation of gene expression. The protein encoded by the WFDC21P gene is a member of the Wilmsen family and is responsible for the regulation of stem cell proliferation and differentiation. The WFDC21P protein has been shown to play a role in the development and progression of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

One of the key functions of the WFDC21P protein is its ability to induce stem cells to differentiate into functional neurons that are capable of replacing lost or damaged neurons in the brain. This has led to the potential use of the WFDC21P protein as a drug target for the treatment of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its role in neurodegenerative diseases, the WFDC21P protein has also been shown to be involved in the development and progression of cancer. Studies have shown that the WFDC21P protein can promote the growth and survival of cancer cells, and that it is expressed in a variety of cancer types, including breast, ovarian, and colorectal cancer. This has led to the potential use of the WFDC21P protein as a biomarker for cancer and as a target for cancer treatments.

Another potential application of the WFDC21P protein is its role in the regulation of autoimmune diseases. Studies have shown that the WFDC21P protein can promote the development and progression of autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis. This has led to the potential use of the WFDC21P protein as a drug target for the treatment of autoimmune diseases.

In conclusion, the WFDC21P protein is a protein that is involved in the development and progression of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. Its function and significance have been studied extensively in the scientific literature, and there is growing interest in using it as a drug target or biomarker. Further research is needed to fully understand the role of the WFDC21P protein in disease and to develop effective treatments.

Protein Name: WAP Four-disulfide Core Domain 21, Pseudogene

More Common Targets

WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B | WNT9A | WNT9B | WRAP53 | WRAP73 | WRN | WRNIP1 | WSB1 | WSB2 | WSCD1 | WSCD2 | WSPAR | WT1 | WT1-AS | WTAP | WTAPP1 | WTIP | WWC1 | WWC2 | WWC2-AS2 | WWC3 | WWOX | WWP1 | WWP2 | WWTR1 | WWTR1-AS1 | XAB2 | XACT | XAF1 | XAGE-4 | XAGE1A | XAGE1B | XAGE1D | XAGE2 | XAGE3 | XAGE5 | XBP1 | XCL1 | XCL2 | XCR1 | XDH | XG | XGY2 | XIAP | XIRP1 | XIRP2 | XIST | XK | XKR3 | XKR4 | XKR5 | XKR6 | XKR7 | XKR8 | XKR9 | XKRX | XKRY | XKRYP7